Drugs Made In America Acquisition (DMAA) Assets (2024 - 2025)
Drugs Made In America Acquisition's (DMAA) quarterly Assets came in at $239.9 million in Q4 2025, up 43456.35% YoY from N/an in Q4 2024, and up 0.96% on a QoQ basis from $237.6 million in Q3 2025.
Drugs Made In America Acquisition (DMAA) Assets (2024 - 2025) Analysis & Trends
Drugs Made In America Acquisition (DMAA) has 2 years of Assets data on file, last reported at $239.9 million in Q4 2025.
- Quarterly Assets rose 43456.35% year-over-year to $239.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $239.9 million (up 43456.35% YoY) and the FY2025 annual result came in at $239.9 million, up 43456.35% from the prior year.
- Assets climbed to $239.9 million in Q4 2025, from $237.6 million in the prior quarter.
- In the past five years, Assets ranged from a high of $239.9 million in Q4 2025 to a low of $550824.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oxley Bridge Acquisition | 585.76 Mn | 585.76 Mn | - | 261.48 Mn |
| 2 | Launch Two Acquisition | 557.86 Mn | 557.86 Mn | - | 245.80 Mn |
| 3 | Drugs Made In America Acquisition | 506.00 Mn | 506.00 Mn | - | 514.10 Mn |
| 4 | Cantor Equity Partners IV | 468.00 Mn | 468.00 Mn | - | 464.99 Mn |
| 5 | GP-Act III Acquisition | 401.06 Mn | 401.06 Mn | - | 98.35 Mn |
| 6 | Aldel Financial | 397.49 Mn | 397.49 Mn | - | 247.73 Mn |
| 7 | Republic Digital Acquisition | 389.25 Mn | 388.51 Mn | - | 314.37 Mn |
| 8 | Gores Holdings X | 385.06 Mn | 384.87 Mn | - | 374.60 Mn |
| 9 | Agriculture & Natural Solutions Acquisition | 377.29 Mn | 377.04 Mn | - | 376.80 Mn |
| 10 | Drugs Made In America Acquisition | 215.82 Mn | 215.82 Mn | - | 146.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 239.92 Mn |
| Sep 30, 2025 | 237.63 Mn |
| Jun 30, 2025 | 235.21 Mn |
| Mar 31, 2025 | 232.81 Mn |
| Dec 31, 2024 | 550,824.00 |